A large group of people began to gather in Plaza de Mayo to participate in the World Marijuana March to the National Congress to protest against the criminalization of cannabis cultivation and users.
Members of Liberty Flowers, a “solidarity cannabis” group, as one of its members called it, highlighted the advances “by leaps and bounds” of regulations in the country. However, he maintained that “there are still legal grays” and assured that “there are many people deprived of their liberty for farming.”
Interviewed by the television signal C5N, the spokesperson for Flores de la Libertad praised the legal advances and cited as an example of this the Registry of the Cannabis Program (Reprocann), in which patients who have an indication of using cannabis for the purpose of and may be authorized to cultivate for themselves, through a family member or another person, or through a civil society organization.
“The law is ambiguous, although, in any case, considerable progress has been made in these five years in terms of regulation, by leaps and bounds,” he said. And he added: “There are legal grays, there are daily raids in the country. So we are carrying out an illegal activity, but in some way we are regulating it.”
Some protesters claimed “advance education to the Judiciary” to end the criminalization of cultivators and recreational users of cannabis.
“We defend that the recreational use of cannabis, as some call it, is truly therapeutic. Around here, someone smokes because otherwise they cannot sleep and that is therapeutic use,” they said.
Since noon in the Buenos Aires Plaza de Mayo stands of various organizations and social groups were posted.
One of them was that of Mama Cultiva Argentina. Valeria Salech, founder of this self-management group and mother of Emiliano, who suffers from refractory epilepsy, maintained that the regulation approved yesterday by Deputies -already had half a sanction from the Senate- is “good news because it will complement” the Law of Medicinal Use of the Plant of Cannabis and Its Derivatives No. 27,350, which -he considered- “had a ceiling because it promoted medical and scientific research but did not generate access to therapies, for which the generation of an industry is required in the medium and long term both for the medicinal use and for industrial use”.
